Genzyme
Genzyme was a biotechnology company developing diagnostic enzyme products with applications in the diagnostic process of various chronic diseases. The company was acquired by Sanofi in 2011, and rebranded as Senofi Genzyme.
All edits
Genzyme
Genzyme was a biotechnology company developing diagnostic enzyme products with applications in the diagnostic process of various chronic diseases. The company was acquired by Sanofi in 2011, and rebranded as Senofi Genzyme.
February 3, 2022
Senofi Genzyme and Sanofi Pasteur are fully integrated into the Sanofi company and brand.
April 8, 2011
Genzyme
Genzyme was a biotechnology company developing diagnostic enzyme products with applications in the diagnostic process of various chronic diseases. The company was acquired by Sanofi in 2011.
Genzyme is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Founded on January 1, 1981, it operates as a subsidiary of Sanofi. The company is active in various industries, including healthcare, medicine, research and development, biotechnology, and infectious disease (medical specialty).
Genzyme's legal name is Genzyme Limited, and it is classified as a public limited company. The company's stock symbol is GENZ, and it has a legal entity identifier of 549300ZNNO34O8GXUE47. Genzyme has been assigned 315 patents.
The company's CEO is Paul Hudson, and its CFO is Jean-Baptiste Chasseloup de Chatillon. Genzyme's board of directors includes Gilles Schnepp, Patrick Kron, Lise Kingo, Rachel Duan, Christophe Babule, Wolfgang Laux, Barbara Lavernos, Fabienne Lecorvaisier, Diane Souza, Thomas Südhof, Ceng-Yann Tran, Serge Weinberg, Carole Ferrand, Emile Voest, and Antoine Yver.
Genzyme has a presence on various social media platforms, including Twitter, Instagram, Facebook, and YouTube. The company's official websites can be found at http://genzyme.com and https://genzyme.co.uk.
Nautilus, Inc. is a public company that specializes in the design, development, and marketing of fitness equipment. The company was founded on January 1, 1986, and is headquartered in Vancouver, Washington. Nautilus, Inc. is the parent organization of Bowflex, a well-known brand in the fitness industry. The company is listed on the New York Stock Exchange under the stock symbol NLS.
Genzyme is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Founded on January 1, 1981, it operates as a subsidiary of Sanofi. The company is active in various industries, including healthcare, medicine, research and development, biotechnology, and infectious disease (medical specialty).
Nautilus, Inc. has been assigned 180 patents, showcasing its commitment to innovation in the fitness industry. The company operates in a B2B2C model, catering to both businesses and consumers. It is active in the tourism, travel, and boating industries.
Genzyme's legal name is Genzyme Limited, and it is classified as a public limited company. The company's stock symbol is GENZ, and it has a legal entity identifier of 549300ZNNO34O8GXUE47. Genzyme has been assigned 315 patents.
The company maintains a strong online presence, with official accounts on various social media platforms. Nautilus, Inc. can be found on Twitter at https://twitter.com/nautilusfitness, Facebook at https://www.facebook.com/nautilus, and LinkedIn at https://www.linkedin.com/company/3090059?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A3090059%2Cidx%3A2-1-2%2CtarId%3A1480333202497%2Ctas%3Anautal. The company also has a blog at http://blog.nautal.com/ and an official website at http://nautilusinc.com.
The company's CEO is Paul Hudson, and its CFO is Jean-Baptiste Chasseloup de Chatillon. Genzyme's board of directors includes Gilles Schnepp, Patrick Kron, Lise Kingo, Rachel Duan, Christophe Babule, Wolfgang Laux, Barbara Lavernos, Fabienne Lecorvaisier, Diane Souza, Thomas Südhof, Ceng-Yann Tran, Serge Weinberg, Carole Ferrand, Emile Voest, and Antoine Yver.
Nautilus, Inc. is incorporated in the state of Washington and has an IRS number of 943002667. The company's CIK number can be found at https://www.sec.gov/cgi-bin/browse-edgar?CIK=1078207.
Genzyme has a presence on various social media platforms, including Twitter, Instagram, Facebook, and YouTube. The company's official websites can be found at http://genzyme.com and https://genzyme.co.uk.
Nautilus, Inc. is a public company that specializes in the design, development, and marketing of fitness equipment. The company was founded on January 1, 1986, and is headquartered in Vancouver, Washington. Nautilus, Inc. is the parent organization of Bowflex, a well-known brand in the fitness industry. The company is listed on the New York Stock Exchange under the stock symbol NLS.
Nautilus, Inc. has been assigned 180 patents, showcasing its commitment to innovation in the fitness industry. The company operates in a B2B2C model, catering to both businesses and consumers. It is active in the tourism, travel, and boating industries.
The company maintains a strong online presence, with official accounts on various social media platforms. Nautilus, Inc. can be found on Twitter at https://twitter.com/nautilusfitness, Facebook at https://www.facebook.com/nautilus, and LinkedIn at https://www.linkedin.com/company/3090059?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A3090059%2Cidx%3A2-1-2%2CtarId%3A1480333202497%2Ctas%3Anautal. The company also has a blog at http://blog.nautal.com/ and an official website at http://nautilusinc.com.
Nautilus, Inc. is incorporated in the state of Washington and has an IRS number of 943002667. The company's CIK number can be found at https://www.sec.gov/cgi-bin/browse-edgar?CIK=1078207.
Find more companies like Genzyme
